2023 Form 5500 filing — Cytokinetics, Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241004175736NAL0021007904001) for Cytokinetics, Inc. 401(K) Plan, reported by Cytokinetics, Inc. under EIN 94-3291317 and plan number 001. It reports 506 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241004175736NAL0021007904001
Filing year
2023
Form type
2
Plan sponsor
Cytokinetics, Inc.
EIN
94-3291317
Plan number
001
Location
South San Francisco, CA
Participants
506
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$65,632,723
Total liabilities (EOY)
$0
Net assets (EOY)
$65,632,723
Employer contributions
$1,825,687
Participant contributions
$8,140,373
Total income / additions
$22,758,526
Benefits paid
$3,763,500
Administrative expenses
$2,266
Total expenses
$3,774,013
Net increase / (decrease)
$18,984,513
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Fidelity Investments InstitutionalRECORDKEEPER$2,266$0

Related Form 5500 pages